Cargando…
Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism
Anticoagulant treatment of acute pulmonary embolism (PE) has traditionally been hospital-based. The lesser need for monitoring with the increasingly used direct acting oral anticoagulants (DOAC) in comparison to warfarin potentially facilitates outpatient treatment of PE with these drugs. This study...
Autores principales: | Ghazvinian, R., Gottsäter, A., Elf, J. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818558/ https://www.ncbi.nlm.nih.gov/pubmed/29305675 http://dx.doi.org/10.1007/s11239-017-1607-9 |
Ejemplares similares
-
Outpatient Treatment in Low-Risk Pulmonary Embolism Patients
Receiving Direct Acting Oral Anticoagulants Is Associated With Cost
Savings
por: Ghazvinian, Raein, et al.
Publicado: (2020) -
Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis
por: Montiel, Francisco Sánchez, et al.
Publicado: (2017) -
Is it safe to withhold long-term anticoagulation therapy in patients with small pulmonary emboli diagnosed by SPECT scintigraphy?
por: Ghazvinian, R., et al.
Publicado: (2016) -
Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2018) -
New Oral Anticoagulants in the Treatment of Pulmonary Embolism: Efficacy, Bleeding Risk, and Monitoring
por: Rudd, Kelly M., et al.
Publicado: (2013)